Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Pandemrix – Adjuvanted H1N1 Influenza Vaccine

Drug

Pandemrix

Company / Licensee

GlaxoSmithKline

Therapy Class

Anti-viral agents

Product Description

Pandemic (H1N1) AS03 adjuvanted vaccine

Current Indication

Swine flu (H1N1)

Market Sector

Anti-infectives

Development Status

Approved by the European Commission
Expand

Go Top